FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

412402004: Hepatitis B virus recombinant vaccine (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2467854015 Hepatitis B virus recombinant vaccine (substance) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core
    2473980018 Hepatitis B virus recombinant vaccine en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Hepatitis B virus recombinant vaccine Is a Hepatitis B virus vaccine false Inferred relationship Some
    Hepatitis B virus recombinant vaccine Is a Drug allergen false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Hepatitis B virus recombinant vaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B virus recombinant vaccine Inferred relationship Some 1
    Hepatitis b virus vaccine re 10mcg/0.5mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B virus recombinant vaccine Inferred relationship Some
    Hepatitis b virus vaccine re 10mcg/0.5 mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B virus recombinant vaccine Inferred relationship Some
    Hepatitis b virus vaccine re 10mcg/.5mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B virus recombinant vaccine Inferred relationship Some
    Hepatitis B (rDNA) vaccine injection 20micrograms/ml 0.5ml pre-filled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B virus recombinant vaccine Inferred relationship Some
    Haemophilus influenzae Type b + recombinant hepatitis B virus vaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B virus recombinant vaccine Inferred relationship Some 2
    Haemophilus influenzae type b 7.5micrograms/recombinant hepatitis B virus surface antigen 5micrograms injection solution 0.5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B virus recombinant vaccine Inferred relationship Some
    Recombinant hepatitis B virus surface antigen 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis 25micrograms injection solution 0.5mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B virus recombinant vaccine Inferred relationship Some
    Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B virus recombinant vaccine Inferred relationship Some
    Diphtheria + tetanus + pertussis + recombinant hepatitis B virus vaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B virus recombinant vaccine Inferred relationship Some 3
    Diphtheria + tetanus + pertussis + poliomyelitis + recombinant hepatitis B virus vaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B virus recombinant vaccine Inferred relationship Some 4
    Diphtheria + tetanus + pertussis + poliomyelitis + recombinant hepatitis B virus + recombinant haemophilus influenzae type B vaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B virus recombinant vaccine Inferred relationship Some 5
    Haemophilus influenzae type b 7.5micrograms/recombinant hepatitis B virus surface antigen 5micrograms injection solution 0.5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B virus recombinant vaccine Inferred relationship Some 1
    Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B virus recombinant vaccine Inferred relationship Some 6
    Recombinant hepatitis B virus surface antigen 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis 25micrograms injection solution 0.5mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Hepatitis B virus recombinant vaccine Inferred relationship Some 1

    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start